Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumors
×
pembrolizumab
×
Clear all
Filters
3
NCT04074759
2025-01-23
FPT155-001
Five Prime Therapeutics, Inc.
Phase 1
Terminated
80 enrolled
49 charts